In 2011, the International Ki-67 in Breast Cancer Working Group reported a first recommendation on Ki-67 Li assessment, which addressed also the handling of heterogeneous tumor areas and the presence of as condensed areas, so called hot-spots within the tumor [17]. This evidence concerns the gene MKI67 and breast carcinoma.